参考文献/References:
[ 1 ] Cua DJ,Tato CM．Innate IL-17-producing cells：the sentinels of the immune system[J]．Nat Rev Immunol,2010,10（7）：479-489.
[ 2 ] Iwakura Y,Ishigame H,Saijo S,et al．Functional specialization of interleukin-17 family members[J]．Immunity,2011,34（2）：149-162.
[ 3 ] Gaffen SL．Structure and signalling in the IL-17 receptor family[J]．Nat Rev Immunol,2009,9（8）：556-567.
[ 4 ] Song X,Qian Y．The activation and regulation of IL-17 receptor mediated signaling[J]．Cytokine,2013,62（2）：175-182.
[ 5 ] Horiuchi K,Kimura T,Miyamoto T,et al．Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF[J]．J Immunol,2009,182（4）：2093-2101.
[ 6 ] DeSelm CJ,Takahata Y,Warren J,et al．IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner[J]．J Cell Biochem,2012,113（9）：2895-2902.
[ 7 ] Tyagi AM,Srivastava K,Mansoori MN,et al．Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells：a new candidate in the pathogenesis of osteoporosis[J]．PLoS One,2012,7（9）：e44552.
[ 8 ] Li N,Wang JC,Liang TH,et al．Pathologic finding of increased expression of interleukin-17 in the synovial tissue of rheumatoid arthritis patients[J]．Int J Clin Exp Pathol,2013,6（7）：1375-1379.
[ 9 ] Gümüｓ P,Buduneli E,Biyiko?lu B,et al．Gingival crevicular fluid,serum levels of receptor activator of nuclear factor-kappa B ligand,osteoprotegerin,and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease[J]．J Periodontol,2013,84（11）：1627-1637.
[10] Fabbrini E,Cella M,McCartney SA,et al．Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals[J]．Gastroenterology,2013,145（2）：366-374.e1-e3.
[11] Won HY,Lee JA,Park ZS,et al．Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T-cells in TallyHo/JngJ mice[J]．PLoS One,2011,6（3）：e18168.
[12] Bai YD,Yang FS,Xuan K,et al．Inhibition of RANK/RANKL signal transduction pathway：a promising approach for osteo-porosis treatment[J]．Med Hypotheses,2008,71（2）：256-258.
[13] Yuan FL,Li X,Lu WG,et al．Type 17 T-helper cells might be a promising therapeutic target for osteoporosis[J]．Mol Biol Rep,2012,39（1）：771-774.
[14] Adamopoulos IE,Chao CC,Geissler R,et al．Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors[J]． Arthritis Res Ther,2010,12（1）：R29.
[15] Ju JH,Cho ML,Jhun JY,et al．Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T-cells in collagen-induced arthritis[J]． Immunol Lett,2008,117（1）：16-25.
[16] Li X,Yuan FL,Lu WG,et al．The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis[J]．Biochem Biophys Res Commun,2010,397（2）：131-135.
[17] Chabaud M,Lubberts E,Joosten L,et al．IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis[J]．Arthritis Res,2001,3（3）：168-177.
[18] Moon YM,Yoon BY,Her YM,et al．IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis[J]．Arthritis Res Ther,2012,14（6）：R246.
[19] Zhang S,Zhang Q,Zhang L,et al．Expression of ghrelin and leptin during the development of type 2 diabetes mellitus in a rat model[J]． Mol Med Rep,2012,7（1）：223-228.
[20] Coppari R,Bj?rbaek C．Leptin revisited: its mechanism of action and potential for treating diabetes[J]．Nat Rev Drug Discov,2012,11（9）：692-708.
[21] Deselm CJ,Zou W,Teitelbaum SL．Halofuginone prevents estrogen-deficient osteoporosis in mice[J]．J Cell Biochem,2012,
113（10）：3086-3092.
[22] Colin EM,Asmawidjaja PS,van Hamburg JP,et al．1,25-dihydroxyvitamin D3 modulates Th17 polarization and inter-leukin-22 expression by memory T cells from patients with early rheumatoid arthritis[J]．Arthritis Rheum,2010,62（1）：132-142.
[23] Korczowska I,Lacki JK,Hrycaj P．Influence of infliximab on cytokines network and markers of bone remodeling in rheumatoid arthritis patients[J]．Yonsei Med J,2013,54（1）：183-188.
[24] Yago T,Nanke Y,Kawamoto M,et al．Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation[J]．Cytokine,2012,59（2）：252-257.
相似文献/References:
[1]姜艳,孟迅吾.雷尼酸锶防治骨质疏松的机制和临床研究[J].国际内分泌代谢杂志,2007,(04):247.
[2]郭丽婷,郝帅,高志红.2型糖尿病患者骨代谢生化指标和钙调激素
与骨密度关系的研究[J].国际内分泌代谢杂志,2015,(02):88.[doi:10.3760/cma.j.issn.1673-4157.2015.02.005]
Guo Liting,Hao Shuai,Gao Zhihong..Research on the relationship between bone mineral density and biochemical index of bone metabolism ,calmodulin hormone in type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(02):88.[doi:10.3760/cma.j.issn.1673-4157.2015.02.005]
[3]尹飞,李菲,李志红.亚临床甲状腺功能异常与骨质疏松[J].国际内分泌代谢杂志,2015,(04):258.[doi:10.3760/cma.j.issn.1673-4157.2015.04.012]
Yin Fei,Li Fei,Li Zhihong..Subclinical thyroid dysfunction and osteoporosis[J].International Journal of Endocrinology and Metabolism,2015,(02):258.[doi:10.3760/cma.j.issn.1673-4157.2015.04.012]
[4]王涛,马信龙.骨质疏松发病机制研究进展[J].国际内分泌代谢杂志,2014,(02):99.[doi:10.3760/cma.j.issn.1673-4157.2014.02.008]
Wang Tao,Ma Xinlong..Research progress on pathogenesis of osteoporosis[J].International Journal of Endocrinology and Metabolism,2014,(02):99.[doi:10.3760/cma.j.issn.1673-4157.2014.02.008]
[5]田甜,沈山梅.肠促胰素与骨质疏松[J].国际内分泌代谢杂志,2016,36(05):320.[doi:10.3760/cma.j.issn.1673-4157.2016.05.09]
Tian Tian,Shen Shanmei.Incretin and osteoporosis[J].International Journal of Endocrinology and Metabolism,2016,36(02):320.[doi:10.3760/cma.j.issn.1673-4157.2016.05.09]